Global livestockcontributes 14.5%of all manmade greenhouse gas emissions.
Some of that revamping is happening in the lab, with cell biology taking centre stage.
UK-based cultivated meat startup Uncommon announced today it has raised $30mn (28mn) in Series A funding.
If RNA sounds familiar to you, it is probably due to the mRNA vaccines developed to fight COVID-19.
It’s free, every week, in your inbox.
Furthermore, the company says it will double its team over the next 18 months.
Will cultivated meat succeed where plant-based alternatives appear to have failed?
Lab-grown meat doesnt have that problem since it is, well, actual meat.
Cells are taken from an otherwise unharmed animal and then cultivated in a lab setting.
Indeed, Uncommon says it aims to own 5% of the global pork market by 2035.
However, in the UK, investmentsrose by 400%.
Hehas backed over 100 companiesover the years, including several biotech startups, for instance, Elon Musks Neuralink.
Whats more, it may help assist with food security.
The US also approved the first cultivated meat product (chicken) in November 2022.
Story byLinnea Ahlgren
Linnea is the senior editor at TNW, having joined in April 2023.
Dabbles in gaming and fitness wearables.
But first, coffee.
